P
US10174284B2ActiveUtilityPatentIndex 45

Medium, for culturing corneal endothelial cells, containing conditioned medium from mesenchymal stem cells

Assignee: JAPAN CHEM RESPriority: Sep 7, 2012Filed: Sep 5, 2013Granted: Jan 8, 2019
Est. expirySep 7, 2032(~6.2 yrs left)· nominal 20-yr term from priority
Inventors:HAGIYA MICHIOIMAGAWA KIWAMUHOSODA YUUKIKOIZUMI NORIKOOKUMURA NAOKINAKAHARA MAKIKOKINOSHITA SHIGERU
C12N 2502/1358C12N 5/0621C12N 5/0018A61K 35/44A61P 27/02C12N 2500/84A61K 35/30
45
PatentIndex Score
0
Cited by
30
References
14
Claims

Abstract

[Problem] To provide, in order to manufacture cells to transplant into patients with corneal endothelial failure, a medium used to culture corneal endothelial cells obtained from human corneal tissue and grow said cells while maintaining the morphology thereof as corneal endothelial cells. [Solution] A medium containing a conditioned medium from mesenchymal stem cells; and a method in which said medium is used to culture corneal endothelial cells.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for culturing human corneal endothelial cells, which comprises
 a step for preparing a conditioned medium by culturing a mesenchymal stem cell in a medium containing chondroitin sulfate, 
 a step for separating the human corneal endothelial cells from a corneal tissue, and 
 a step for propagating the separated human corneal endothelial cells by a culture using a medium for corneal endothelial cell culture consisting of the conditioned medium of mesenchymal stem cells or containing the conditioned medium wherein the mesenchymal stem cell is a human mesenchymal stem cell and wherein the concentration of chondroitin sulfate is 0.04 to 0.12 % (w/v). 
 
     
     
       2. The method according to  claim 1 , wherein the medium for corneal endothelial cell culture contains the conditioned medium in a proportion of 0.5 to 50 % (v/v). 
     
     
       3. The method according to  claim 1 , wherein the medium for corneal endothelial cell culture contains the conditioned medium in a proportion of 1to 10 % (v/v). 
     
     
       4. The method according to  claim 1 , wherein the concentration of chondroitin sulfate is 0.08 % (w/v). 
     
     
       5. The method according to  claim 1 , wherein the mesenchymal stem cell is a mesenchymal stem cell derived from human bone marrow. 
     
     
       6. A method for culturing human corneal endothelial cells, which comprises
 a step for preparing a conditioned medium by culturing a mesenchymal stem cell in a medium containing chondroitin sulfate, 
 a step for preparing a concentrated solution by filtration concentration of the conditioned medium, 
 a step for separating the human corneal endothelial cells from a corneal tissue, and 
 a step for propagating the separated human corneal endothelial cells by a culture using a medium for corneal endothelial cell culture containing the concentrated solution wherein the mesenchymal stem cell is a human mesenchymal stem cell and wherein the concentration of chondroitin sulfate is 0.04 to 0.12 % (w/v). 
 
     
     
       7. The method according to  claim 6 , wherein the concentration rate in the filtration concentration is 2 to 30 times. 
     
     
       8. The method according to  claim 6 , wherein the concentration rate in the filtration concentration is 15 to 20 times. 
     
     
       9. The method according to  claim 6 , wherein the medium for corneal endothelial cell culture contains the concentrated solution at a proportion of 0.5 to 50 % (v/v). 
     
     
       10. The method according to  claim 6 , wherein the medium for corneal endothelial cell culture contains the concentrated solution at a proportion of 1 to 10 % (v/v). 
     
     
       11. The method according to  claim 6 , wherein the concentration of chondroitin sulfate is 0.08 % (w/v). 
     
     
       12. The method according to  claim 6 , wherein the mesenchymal stem cell is a mesenchymal stem cell derived from human bone marrow. 
     
     
       13. The method according to  claim 1 , wherein the medium for corneal endothelial cell culture is not added with nerve growth factor. 
     
     
       14. The method according to  claim 6 , wherein the medium for corneal endothelial cell culture is not added with nerve growth factor.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.